Researchers presented a deep learning framework, DeepAIR, to accurately predict adaptive immune receptor (AIR)-antigen binding.
FDA panel backs Guardant’s blood test for colon cancer
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: A Food and Drug Administration